Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety & efficacy of SEROQUEL SR™ in the treatment
of major depressive disorder compared to placebo & to evaluate quality of sleep, overall
quality of life, and effect, if any, on anxiety and satisfaction PLEASE NOTE: Seroquel SR and
Seroquel XR refer to the same formulation. The SR designation was changed to XR after
consultation with FDA.